• Privacy Policy
  • Contacts
+39 085 295166 info@nsmcongressi.it
Haemosafety Haemosafety
  • Who we are
  • Topics
    • Emerging infections
    • Prion diseases
    • Viral infections: Epidemiology and treatment
    • Security in replacement therapy, pharmacovigilance and haemovigilance
    • Therapeutic advances
    • Zika Virus
  • Link
  • Subscribe to the newsletter
  • en
  • it
Home

Archive for Category: sicurezza terapia

Mar 12 2020

INACTIVATION OF THREE EMERGING VIRUSES – SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS, CRIMEAN-CONGO HAEMORRHAGIC FEVER VIRUS AND NIPAH VIRUS – IN PLATELET CONCENTRATES BY ULTRAVIOLET C LIGHT AND IN PLASMA BY METHYLENE BLUE PLUS VISIBLE LIGHT

sicurezza terapia

Emerging viruses like severe acute respiratory syndrome coronavirus (SARS-CoV), Crimean-Congo haemorrhagic fever virus (CCHFV)...

Read More

Mar 11 2020

Coronavirus Disease 2019: Coronaviruses and Blood Safety

sicurezza terapia

With the outbreak of unknown pneumonia in Wuhan, China, in December 2019, a new coronavirus,...

Read More

Feb 17 2020

Current state of play regarding dental extractions in patients with haemophilia: Consensus or evidence‐based practice? A review of the literature

sicurezza terapia

Tooth extractions are quite common surgical procedures in patients with haemophilia, in particular in...

Read More

Feb 16 2020

A retrospective Analysis of the Use of 3-Factor Prothrombin Complex Concentrates for Refractory Bleeding After Cardiopulmonary Bypass in Children Undergoing Heart Surgery: A Matched Case-Control Study

sicurezza terapia

The 3-factor prothrombin complex concentrate (3FPCC) may be used off-label to treat refractory bleeding...

Read More

Feb 15 2020

Early administration of fibrinogen concentrate is associated with improved survival among severe trauma patients: a single-centre propensity score-matched analysis

sicurezza terapia

Low fibrinogen levels after severe trauma are associated with haemostatic impairment, massive bleeding, and...

Read More

Jan 21 2020

Prevalence, incidence and residual risk of transfusion-transmitted hepatitis B virus infection in Italy from 2009 to 2018

sicurezza terapia

In Italy, nucleic acid testing for hepatitis B virus (HBV) in donor screening allows...

Read More

Jan 19 2020

The growing importance of achieving national self-sufficiency in immunoglobulin in Italy. The emergence of a national imperative

sicurezza terapia

The current plasma collection capacity of several countries will be soon unable to afford...

Read More

Jan 17 2020

Decreases in U.S. Blood Donors even if Eligible Donors are increasing in the last ten years

sicurezza terapia

Red Blood Cells (RBC) and whole blood cell transfusions have been reported to decrease...

Read More

Jan 15 2020

Mechanisms and potential implications of ineffective platelets transfusion

sicurezza terapia

Platelet transfusions may be ineffective for bleeding prevention in subjects with inherited platelet disorders...

Read More

Dec 19 2019

Uncovering occult hepatitis B in blood donations: a tale of two worlds

sicurezza terapia

For almost fifty years, improvements in donor selection and screening have led to a...

Read More
Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Next
Copyright © 2021 Non Solo Meeting srl
CCIAA di Pescara n. 93080 - P.iva 01434640684 All Rights Reserved